Sequence conservation of pilus subunits in Neisseria meningitidis. (Q54428810)

29 May 2018

title

Sequence conservation of pilus subunits in Neisseria meningitidis. (English)

1 reference

29 May 2018

main subject

Neisseria meningitidis

1 reference

7

1 reference

29 May 2018

Ray Borrow

4

object named as

Ray Borrow

1 reference

29 May 2018

Ana Cehovin

1

1 reference

29 May 2018

Megan Winterbotham

2

1 reference

29 May 2018

Jay Lucidarme

3

1 reference

29 May 2018

Christoph M Tang

5

1 reference

29 May 2018

Rachel M Exley

6

1 reference

29 May 2018

language of work or name

English

0 references

publication date

8 May 2010

1 reference

29 May 2018

published in

Vaccine

1 reference

29 May 2018

volume

28

1 reference

29 May 2018

page(s)

4817-4826

1 reference

29 May 2018

issue

30

1 reference

29 May 2018

Global epidemiology of meningococcal disease.

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.04.065

Meningococcal C conjugate vaccine: the experience in England and Wales

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.04.065

Meningococcal carriage and disease--population biology and evolution

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.04.065

Genetics and evolution of Neisseria meningitidis: importance for the epidemiology of meningococcal disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.04.065

Challenges and progress in the development of a serogroup B meningococcal vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.04.065

A universal vaccine for serogroup B meningococcus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.04.065

Prevalence and sequence variations of the genes encoding the five antigens included in the novel 5CVMB vaccine covering group B meningococcal disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.04.065

Outer membrane protein (OMP) based vaccine for Neisseria meningitidis serogroup B

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.04.065

Gonococcal Pili: Safety and Immunogenicity in Humans and Antibody Function in Vitro

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.04.065

Gonococcal pilus vaccine. Studies of antigenicity and inhibition of attachment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.04.065

Type IV pili: e pluribus unum?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.04.065

Studies on gonococcus infection. IV. Pili: their role in attachment of gonococci to tissue culture cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.04.065

The role of pili in the interactions of pathogenic Neisseria with cultured human endothelial cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.04.065

Shuttle mutagenesis of Neisseria gonorrhoeae: pilin null mutations lower DNA transformation competence

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.04.065

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.04.065

Structure and function of pili of pathogenic Neisseria species

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.04.065

Multiple gonococcal pilin antigenic variants are produced during experimental human infections

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.04.065

The repertoire of silent pilus genes in Neisseria gonorrhoeae: evidence for gene conversion.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.04.065

Intragenic recombination leads to pilus antigenic variation in Neisseria gonorrhoeae

7 January 2021

2 references

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.04.065

7 January 2021

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.04.065

inferred from DOI database lookup

7 January 2021

based on heuristic

Prepilin-like molecules in type 4 pilus biogenesis: minor subunits, chaperones or mediators of organelle translocation?

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.04.065

3D structure/function analysis of PilX reveals how minor pilins can modulate the virulence properties of type IV pili

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.04.065

Type IV pilus structure by cryo-electron microscopy and crystallography: implications for pilus assembly and functions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.04.065

Competence for natural transformation in Neisseria gonorrhoeae: components of DNA binding and uptake linked to type IV pilus expression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.04.065

PilX, a pilus-associated protein essential for bacterial aggregation, is a key to pilus-facilitated attachment of Neisseria meningitidis to human cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.04.065

The comP locus of Neisseria gonorrhoeae encodes a type IV prepilin that is dispensable for pilus biogenesis but essential for natural transformation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.04.065

Polymorphisms in pilin glycosylation Locus of Neisseria meningitidis expressing class II pili.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.04.065

Clustal W and Clustal X version 2.0

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.04.065

MEGA4: Molecular Evolutionary Genetics Analysis (MEGA) Software Version 4.0

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.04.065

ESyPred3D: Prediction of proteins 3D structures.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.04.065

Complete Genome Sequence of Neisseria meningitidis Serogroup B Strain MC58

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.04.065

NeMeSys: a biological resource for narrowing the gap between sequence and function in the human pathogen Neisseria meningitidis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.04.065

Complete DNA sequence of a serogroup A strain of Neisseria meningitidis Z2491

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.04.065

Meningococcal genetic variation mechanisms viewed through comparative analysis of serogroup C strain FAM18.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.04.065

Sequence constancies and variations in genes encoding three new meningococcal vaccine candidate antigens

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.04.065

Pilin gene variation in Neisseria gonorrhoeae: reassessing the old paradigms

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.04.065

Distribution and genetic variability of three vaccine components in a panel of strains representative of the diversity of serogroup B meningococcus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.04.065

Antibodies directed against the toxin-coregulated pilus isolated from Vibrio cholerae provide protection in the infant mouse experimental cholera model

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.04.065

Molecular epidemiology of meningococcal disease in England and Wales 1975-1995, before the introduction of serogroup C conjugate vaccines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.04.065

Invasive meningococcal disease in Quebec, Canada, due to an emerging clone of ST-269 serogroup B meningococci with serotype antigen 17 and serosubtype antigen P1.19 (B:17:P1.19).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.04.065

Characterization of fHbp, nhba (gna2132), nadA, porA, sequence type (ST), and genomic presence of IS1301 in group B meningococcal ST269 clonal complex isolates from England and Wales

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.04.065

A comparative analysis of pilin genes from pathogenic and nonpathogenic Neisseria species

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.04.065

Differential distribution of novel restriction-modification systems in clonal lineages of Neisseria meningitidis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.04.065

Identification of the hypervirulent lineages of Neisseria meningitidis, the ST-8 and ST-11 complexes, by using monoclonal antibodies specific to NmeDI.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.04.065

Structure of the fibre-forming protein pilin at 2.6 A resolution

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.04.065

Frequency and rate of pilin antigenic variation of Neisseria meningitidis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.04.065

Severity of meningococcal disease associated with genomic bacterial load

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.04.065

A surveillance network for meningococcal disease in Europe.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.04.065

Fatal outcome from meningococcal disease--an association with meningococcal phenotype but not with reduced susceptibility to benzylpenicillin.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.04.065

Hyperinvasive genotypes of Neisseria meningitidis in France

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.04.065

Emergence of endemic serogroup W135 meningococcal disease associated with a high mortality rate in South Africa

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.04.065

W135 in Africa: origins, problems and perspectives

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.04.065

Conserved virulence of C to B capsule switched Neisseria meningitidis clinical isolates belonging to ET-37/ST-11 clonal complex

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.04.065

Evidence for capsule switching between carried and disease-causing Neisseria meningitidis strains

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.04.065

B:2a:p1.5 meningococcal strains likely arisen from capsular switching event still spreading in Spain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.04.065

Neisseria gonorrhoeae PilV, a type IV pilus-associated protein essential to human epithelial cell adherence

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.04.065

Serologic correlates of protection for evaluating the response to meningococcal vaccines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.04.065

Bactericidal antibody is the immunologic surrogate of protection against meningococcal disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.04.065

Neisseria meningitidis serogroup B: laboratory correlates of protection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.04.065

A conserved DNA sequence is required for efficient gonococcal pilin antigenic variation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.04.065

An alternative DNA structure is necessary for pilin antigenic variation in Neisseria gonorrhoeae

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.04.065

Interaction of Neisseria meningitidis with a polarized monolayer of epithelial cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.04.065

inferred from DOI database lookup

7 January 2021

based on heuristic

Gene conversion involving the pilin structural gene correlates with pilus+ in equilibrium with pilus- changes in Neisseria gonorrhoeae

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.04.065

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/J.VACCINE.2010.04.065

1 reference

29 May 2018

PubMed ID

20457291

1 reference

29 May 2018